Related Experiment Video

Updated: Aug 21, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies

T Crough1, D M Purdie, M Okai

  • 1Department of Medicine, University of Queensland, Brisbane, Australia.

British Journal of Cancer
|November 3, 2004
PubMed

Insights

Immunotherapy targeting natural killer T (NKT) cells is promising. This study found that cancer and prior treatments reduce NKT cell numbers, but they can still expand in response to alpha-galactosylceramide (alpha-GalCer) therapy.

Area of Science:

  • Immunology
  • Cancer Research
  • Immunotherapy

Background:

  • Natural killer T (NKT) cells are crucial immune cells targeted for immunotherapy.
  • Understanding factors affecting NKT cell numbers and function is vital for developing effective NKT cell-based therapies.

Purpose of the Study:

  • To investigate the impact of age, cancer status, and prior anticancer treatments on peripheral blood NKT cell numbers and their expansion capacity.
  • To evaluate the responsiveness of NKT cells from cancer patients to alpha-galactosylceramide (alpha-GalCer) stimulation.

Main Methods:

  • Assessed NKT cell percentage and absolute numbers in 40 healthy donors and 109 solid cancer patients.
  • Analyzed NKT cell responsiveness to alpha-GalCer stimulation in a subset of patients and healthy donors.
  • Correlated NKT cell levels with age, cancer type, and prior treatments like radiation.

Main Results:

  • NKT cell numbers were significantly reduced in melanoma and breast cancer patients.
  • NKT cell numbers decreased with age in healthy donors and were lower in cancer patients irrespective of age and sex.
  • Prior radiation treatment was linked to reduced NKT cells in melanoma patients.
  • Cancer patient NKT cells showed reduced responsiveness but retained significant expansion capacity after alpha-GalCer stimulation.

Conclusions:

  • NKT cell numbers are modulated by age, malignancy, and prior anticancer treatments.
  • Despite reductions, NKT cells in cancer patients remain capable of responding to alpha-GalCer-based immunotherapies, suggesting potential therapeutic utility.

More Related Videos

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...